ERGIC2 Antikörper (C-Term)
-
- Target Alle ERGIC2 Antikörper anzeigen
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
-
Bindungsspezifität
- AA 334-362, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ERGIC2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human ERGIC2 (C-term).
- Aufreinigung
- Affinity Chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 334-362 amino acids from the C-terminal region of Human ERGIC2
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ERGIC2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
- Andere Bezeichnung
- ERGIC2 (ERGIC2 Produkte)
- Hintergrund
- ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).Synonyms: CDA14, ERV41, Endoplasmic reticulum-Golgi intermediate compartment protein 2, PTX1
- Molekulargewicht
- 42549 Da
- Gen-ID
- 51290
- NCBI Accession
- NP_057654
-